Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
-0.12%
$217.75
100% positive prob.
5-Day Prediction
+2.30%
$223.03
100% positive prob.
20-Day Prediction
+2.19%
$222.78
95% positive prob.
SEC 8-K filings with transcript text
Jan 21, 2026 · 100% conf.
1D
-0.12%
$217.75
Act: +0.22%
5D
+2.30%
$223.03
Act: +4.48%
20D
+2.19%
$222.78
Act: +13.25%
jnj-202601210000200406false00002004062026-01-212026-01-210000200406us-gaap:CommonStockMember2026-01-212026-01-210000200406jnj:A1.150NotesDueNovember2028Member2026-01-212026-01-210000200406jnj:A2.700NotesDueFebruary2029Member2026-01-212026-01-210000200406jnj:A3.20NotesDueJune2032Member2026-01-212026-01-210000200406jnj:A3.050NotesDueFebruary2033Member2026-01-212026-01-210000200406jnj:A1.650NotesDueMay2035Member2026-01-212026-01-210000200406jnj:A3.350NotesDueJune2036Member2026-01-212026-01-210000200406jnj:A3.350NotesDueFebruary2037Member2026-01-212026-01-210000200406jnj:A3.550NotesDueJune2044Member2026-01-212026-01-210000200406jnj:A3.600NotesDueFebruary2045Member2026-01-212026-01-210000200406jnj:A3.700NotesDueFebruary2055Member2026-01-212026-01-21
Washington, DC 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 21, 2026 Johnson & Johnson (Exact name of registrant as specified in its charter)
New Jersey1-321522-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number)(IRS Employer Identification No.)
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 732-524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, Par Value $1.00JNJNew York Stock Exchange 1.150% Notes Due November 2028JNJ28New York Stock Exchange 2.700% Notes due February 2029JNJ29BNew York Stock Exchange 3.200% Notes Due June 2032JNJ32New York Stock Exchange 3.050% Notes due February 2033JNJ33BNew York Stock Exchange 1.650% Notes Due May 2035JNJ35New York Stock Exchange 3.350% Notes Due June 2036JNJ36ANew York Stock Exchange 3.350% Notes due February 2037JNJ37BNew York Stock Exchange 3.550% Notes Due June 2044JNJ44New York Stock Exchange 3.600% Notes due February 2045JNJ45New York Stock Exchange 3.700% Notes due February 2055JNJ55New York Stock Exchange
Item 2.02 Results of operations and financial condition On January 21, 2026, Johnson & Johnson (the “Company”) issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the fourth quarter and full year ended December 28, 2025.
Item 9.01 Financial statements and exhibits (d) Exhibits.
Exhibit No.Description of Exhibit 99.1 Press Release dated January 21, 2026 for the period ended December 28, 2025
99.2 Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal fourth quarter and full year
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 21, 2026
(Registrant)
By:/s/ Robert J. Decker, Jr.
Robert J. Decker, Jr. Controller (Principal Accounting Officer)
Oct 14, 2025
jnj-202510140000200406false00002004062025-10-142025-10-140000200406us-gaap:CommonStockMember2025-10-142025-10-140000200406jnj:A1.150NotesDueNovember2028Member2025-10-142025-10-140000200406jnj:A2.700NotesDueFebruary2029Member2025-10-142025-10-140000200406jnj:A3.20NotesDueNovember2032Member2025-10-142025-10-140000200406jnj:A3.050NotesDueFebruary2033Member2025-10-142025-10-140000200406jnj:A1.650NotesDue2035Member2025-10-142025-10-140000200406jnj:A3.350NotesDueNovember2036Member2025-10-142025-10-140000200406jnj:A3.350NotesDueFebruary2037Member2025-10-142025-10-140000200406jnj:A3.550NotesDueNovember2044Member2025-10-142025-10-140000200406jnj:A3.600NotesDueFebruary2045Member2025-10-142025-10-140000200406jnj:A3.700NotesDueFebruary2055Member2025-10-142025-10-14
Washington, DC 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 14, 2025 Johnson & Johnson (Exact name of registrant as specified in its charter)
New Jersey1-321522-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number)(IRS Employer Identification No.)
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 732-524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, Par Value $1.00JNJNew York Stock Exchange 1.150% Notes Due November 2028JNJ28New York Stock Exchange 2.700% Notes due February 2029JNJ29BNew York Stock Exchange 3.200% Notes Due June 2032JNJ32New York Stock Exchange 3.050% Notes due February 2033JNJ33BNew York Stock Exchange 1.650% Notes Due May 2035JNJ35New York Stock Exchange 3.350% Notes Due June 2036JNJ36ANew York Stock Exchange 3.350% Notes due February 2037JNJ37BNew York Stock Exchange 3.550% Notes Due June 2044JNJ44New York Stock Exchange 3.600% Notes due February 2045JNJ45New York Stock Exchange 3.700% Notes due February 2055JNJ55New York Stock Exchange
Item 2.02 Results of operations and financial condition On October 14, 2025, Johnson & Johnson (the “Company”) issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the third quarter ended September 28, 2025.
Item 8.01 Other events On October 14, 2025, the Company issued the attached press release (Exhibit 99.3) announcing its intent to separate the Company's Orthopaedics business.
Item 9.01 Financial statements and exhibits (d) Exhibits.
Exhibit No.Description of Exhibit 99.1 Press Release dated October 14, 2025 for the period ended September 28, 2025
99.2 Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal third quarter and nine months
99.3 Press Release dated October 14, 2025
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 14, 2025
(Registrant)
By:/s/ Robert J. Decker, Jr.
Robert J. Decker, Jr. Controller (Principal Accounting Officer)
Jul 16, 2025
jnj-202507160000200406false00002004062025-07-162025-07-160000200406us-gaap:CommonStockMember2025-07-162025-07-160000200406jnj:A1.150NotesDueNovember2028Member2025-07-162025-07-160000200406jnj:A2.700NotesDueFebruary2029Member2025-07-162025-07-160000200406jnj:A3.20NotesDueNovember2032Member2025-07-162025-07-160000200406jnj:A3.050NotesDueFebruary2033Member2025-07-162025-07-160000200406jnj:A1.650NotesDue2035Member2025-07-162025-07-160000200406jnj:A3.350NotesDueNovember2036Member2025-07-162025-07-160000200406jnj:A3.350NotesDueFebruary2037Member2025-07-162025-07-160000200406jnj:A3.550NotesDueNovember2044Member2025-07-162025-07-160000200406jnj:A3.600NotesDueFebruary2045Member2025-07-162025-07-160000200406jnj:A3.700NotesDueFebruary2055Member2025-07-162025-07-16
Washington, DC 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 16, 2025 Johnson & Johnson (Exact name of registrant as specified in its charter)
New Jersey1-321522-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number)(IRS Employer Identification No.)
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 732-524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT
Title of each classTrading Symbol(s)Name of each exchange on which registered Common Stock, Par Value $1.00JNJNew York Stock Exchange 1.150% Notes Due November 2028JNJ28New York Stock Exchange 2.700% Notes due February 2029JNJ29BNew York Stock Exchange 3.200% Notes Due June 2032JNJ32New York Stock Exchange 3.050% Notes due February 2033JNJ33BNew York Stock Exchange 1.650% Notes Due May 2035JNJ35New York Stock Exchange 3.350% Notes Due June 2036JNJ36ANew York Stock Exchange 3.350% Notes due February 2037JNJ37BNew York Stock Exchange 3.550% Notes Due June 2044JNJ44New York Stock Exchange 3.600% Notes due February 2045JNJ45New York Stock Exchange 3.700% Notes due February 2055JNJ55New York Stock Exchange
Item 2.02 Results of operations and financial condition On July 16, 2025, Johnson & Johnson issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the second quarter ended June 29, 2025.
Item 9.01 Financial statements and exhibits (d) Exhibits.
Exhibit No.Description of Exhibit 99.1 Press Release dated July 16, 2025 for the period ended June 29, 2025
99.2 Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal second quarter and six months
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date:July 16, 2025
(Registrant)
By:/s/ Robert J. Decker, Jr.
Robert J. Decker, Jr. Controller (Principal Accounting Officer)
This page provides Johnson & Johnson (JNJ) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on JNJ's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.